Clinical Trial Update: Outcome of Second Generation Drug-eLuting Stents in Patients With Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating second-generation drug-eluting stents in patients with coronary artery disease and diabetes mellitus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus

Snippet

Sponsor: Policlinico Casilino ASL RMB | Conditions: Coronary Artery Disease, Diabetes Mellitus | Phase 4 | Status: WITHDRAWN